Aug 6, 2024 | Defective Drugs, Defective Product, Medical News, Product Liability
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for Thyroid Eye Disease (TED), a condition that can cause bulging eyes, double vision, and other serious issues. While Tepezza has offered hope to many patients, it has also raised concerns due to...
Jul 23, 2024 | Defective Drugs, Personal Injury, Product Liability
Ozempic, a medication produced by Novo Nordisk, has garnered significant attention not just for its effectiveness in treating type 2 diabetes, but also due to a spate of consumer lawsuits. The medication, which contains the active ingredient semaglutide, has become...
Jun 22, 2024 | Defective Drugs, Defective Product, Ozempic Lawsuits, Product Liability
Weight loss medications, often prescribed for individuals struggling with obesity or related health conditions, can be a powerful tool in the journey towards a healthier weight. However, like all medications, they come with potential side effects. One of the most...
Feb 19, 2024 | Defective Drugs, Defective Product, Ozempic Lawsuit, Product Liability
Ozempic (semaglutide) has garnered attention as a promising medication for managing type 2 diabetes. However, alongside its benefits, concerns have arisen regarding its potential link to gastrointestinal (GI) issues. Some research is suggesting that Ozempic may be...
Jan 18, 2024 | Defective Drugs, Defective Product, Product Liability
Ozempic, a medication designed to manage type 2 diabetes, has gained popularity in recent years for its effectiveness in controlling blood sugar levels. However, alongside its success, there has been a growing number of lawsuits filed against the drug’s...
